Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Vertex nets $488.4mm through follow-on public offering

Executive Summary

Vertex Pharmaceuticals (developing small-molecule therapeutics for cancer, neurology, immune, inflammatory, viral, and respiratory diseases) has netted $488.4mm through the follow-on public offering of 13mm common shares (including the overallotment) at $38.50 apiece.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies